Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the diarylether class of organic compounds. Its chemical formula is C16H10Cl2N6O and it has been referenced in chemical databases under several code names including R129385 and CHEMBL70967. The structure features a triazine core substituted with amino and dichlorophenoxy groups as well as a benzonitrile moiety. It is listed as an experimental compound with no approved therapeutic indications or known clinical development status. There is no publicly available information on its mechanism of action or biological targets; it appears primarily in chemical and structural databases rather than pharmacological literature[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-[4-amino-6-(2,6-dichlorophenoxy)-[1,3,5]triazin-2-ylamino]-benzonitrile.